Oramed Pharmaceuticals Holds Shareholder Vote

Ticker: ORMP · Form: 8-K · Filed: Aug 2, 2024 · CIK: 1176309

Oramed Pharmaceuticals Inc. 8-K Filing Summary
FieldDetail
CompanyOramed Pharmaceuticals Inc. (ORMP)
Form Type8-K
Filed DateAug 2, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.012
Sentimentneutral

Sentiment: neutral

Topics: shareholder-vote, corporate-governance

Related Tickers: ORMP

TL;DR

ORMP held a shareholder vote on Aug 1st. Details TBD.

AI Summary

On August 1, 2024, Oramed Pharmaceuticals Inc. filed an 8-K report indicating that it submitted matters to a vote of its security holders. The filing does not provide details on the specific proposals voted upon or the outcome of the vote.

Why It Matters

Shareholder votes can signal important corporate decisions, such as mergers, executive compensation, or board member elections, which could impact the company's future direction and stock performance.

Risk Assessment

Risk Level: low — This filing is procedural and does not contain new financial information or significant operational changes.

Key Players & Entities

  • ORAMED PHARMACEUTICALS INC. (company) — Registrant
  • August 1, 2024 (date) — Date of earliest event reported
  • 1185 Avenue of the Americas, Third Floor, New York, New York 10036 (address) — Principal Executive Offices

FAQ

What specific matters were submitted for a vote by Oramed Pharmaceuticals Inc. security holders?

The 8-K filing states that matters were submitted to a vote of security holders, but it does not specify what those matters were.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on August 1, 2024.

What is the principal executive office address for Oramed Pharmaceuticals Inc.?

The principal executive office is located at 1185 Avenue of the Americas, Third Floor, New York, New York 10036.

What is the Commission File Number for Oramed Pharmaceuticals Inc.?

The Commission File Number for Oramed Pharmaceuticals Inc. is 001-35813.

What is the IRS Employer Identification Number for Oramed Pharmaceuticals Inc.?

The IRS Employer Identification Number for Oramed Pharmaceuticals Inc. is 98-0376008.

Filing Stats: 621 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2024-08-02 16:05:24

Key Financial Figures

  • $0.012 — ch registered Common Stock, par value $0.012 ORMP The Nasdaq Capital Market, Te

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORAMED PHARMACEUTICALS INC. By: /s/ Nadav Kidron Name: Nadav Kidron Title: President and CEO August 2, 2024 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.